@article{dfb923fb16804ede8b15dc723958492e,
title = "Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy",
keywords = "Immunotherapy, Immune checkpoint inhibitor, Nivolumab, Tumor-infiltrating lymphocytes, TIL, Lung cancer, Nonesmall cell lung cancer, NSCLC, Prognostic, Biomarkers",
author = "I. Gataa and L. Mezquita and C. Rossoni and E. Auclin and M. Kossai and F. Aboubakar and {Le Moulec}, S. and J. Masse and M. Masson and N. Radosevic-Robin and P. Alemany and M. Rouanne and V. Bluthgen and L. Hendriks and C. Caramella and A. Gazzah and D. Planchard and J.P. Pignon and B. Besse and J. Adam",
year = "2021",
month = mar,
day = "1",
doi = "10.1016/j.ejca.2020.10.017",
language = "English",
volume = "145",
pages = "221--229",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "ELSEVIER SCI LTD",
}